Lilly joins molecular glue field with Magnet deal worth up to $1.25B
Another day, another molecular glue deal in the biopharma world.
This time around, it’s Eli Lilly partnering with the private startup Magnet Biomedicine on the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.